NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks of 30U. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.70% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.68% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.39% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.33% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.28% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.07% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.62% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.50% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.04% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 3.80% |
| LQDA | Liquidia Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.74% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| AVDL | Avadel Pharmaceuticals PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.39% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 3.27% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.26% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 3.08% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.84% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.84% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.84% |